Duration of virus shedding after trivalent intranasal live attenuated influenza vaccination in adults.

Talbot, Thomas R; Crocker, Deidre D; Peters, Jody; Doersam, Jennifer K; Ikizler, Mine R; Sannella, Edith; Wright, Peter E; Edwards, Kathryn M

Talbot, Thomas R; Crocker, Deidre D; Peters, Jody; Doersam, Jennifer K; Ikizler, Mine R; Sannella, Edith; Wright, Peter E; Edwards, Kathryn M.

Affiliation

Talbot TR; Departments of Medicine and Preventive Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. tom.talbot@vanderbilt.edu

Infect Control Hosp Epidemiol ; 26(5): 494-500, 2005 May.

Article in En | MEDLINE | ID: mdl-15954490

Subject(s)

Influenza Vaccines/administration & dosage; Orthomyxoviridae/isolation & purification; Virus Shedding; Administration, Intranasal; Adolescent; Adult; Female; Humans; Immunoglobulin A/analysis; Male; Middle Aged; Orthomyxoviridae/classification; Prospective Studies; United States

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Orthomyxoviridae / Influenza Vaccines / Virus Shedding Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Infect Control Hosp Epidemiol Journal subject: DOENCAS TRANSMISSIVEIS / ENFERMAGEM / EPIDEMIOLOGIA / HOSPITAIS Year: 2005 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links